Select Medical reaffirmed earnings guidance for the year 2024. The company expects revenue to be in the range of $6.9 billion to $7.1 billion, fully diluted earnings per share to be in the range of $1.95 to $2.19.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
33.93 USD | -0.85% | +1.01% | +44.38% |
06/05 | UBS Adjusts Select Medical Price Target to $34 From $31, Maintains Neutral Rating | MT |
06/05 | Benchmark Adjusts Price Target on Select Medical Holdings to $42 From $39, Maintains Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.38% | 4.41B | |
+19.28% | 84.56B | |
-26.95% | 72.41B | |
+1.83% | 27.73B | |
-7.35% | 17.75B | |
-0.43% | 17.11B | |
+4.69% | 16.03B | |
+8.14% | 13.72B | |
+69.96% | 13.07B | |
+6.82% | 12.91B |
- Stock Market
- Equities
- SEM Stock
- News Select Medical Holdings Corporation
- Select Medical Reaffirms Earnings Guidance for the Year 2024